See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2012_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,092,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 994,000 |
| 3 | remainder_Assets | 26,544,000 |
| 4 | LiabilitiesCurrent | 8,944,000 |
| 5 | LiabilitiesNoncurrent | 229,000 |
| 6 | remainder_Liabilities | 2,489,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,153,000 |
| 9 | ResearchAndDevelopmentExpense | 35,441,000 |
| 10 | remainder_Expenses | 45,000 |
| 11 | remainder_Revenues | 247,000 |
| 12 | remainder_NetIncome | 186,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 82,630,000 |
| 1 | Liabilities | 11,662,000 |
| 2 | Expenses | 44,639,000 |
| 3 | Revenues | 247,000 |
| 4 | StockholdersEquity | 70,968,000 |
| 5 | NetIncome | -44,206,000 |
| 6 | ComprehensiveNetIncome | -44,206,000 |
| 7 | BaseVar | 69,682,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.34 |
| 9 | EconomicCapitalRatio | 3.25 |
Edgar->Model Mapping
Feature Distribution
